abstract |
The present invention relates to pyrazolopyrimidine derivatives of formula (I): wherein R 1 to R 4 and A are as defined in the specification, a process for their preparation, their use for the treatment or prevention of metabotropic glutamate receptor mediated disorders, their use in the preparation of medicaments for the treatment of such disorders and pharmaceutical preparations containing said derivatives. |